Gene variant that protects against cardiovascular diseases hints at safer treatments

Lowering the activity of interleukin-6 (IL-6)—a key immune signal regulating inflammatory responses in the body—could reduce the risk of cardiovascular disease without making people more vulnerable to infections, according to new research from LMU’s Institute for Stroke and Dementia Research and international collaborators.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup